Starling Oncology, Inc.
STLNW- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $706.5K in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Starling Oncology, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- −1 vs. Q1 2022
- Shares held
- 3.36M
- +11.0K (+0.3%) vs. Q1 2022
- Total value
- $7.67M
- −$3.56M (−31.7%) vs. Q1 2022
- New holders
- 0
- 3 more added
- Sold out
- 1
- 3 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STLNW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $706.5K |
| Q1 2026 | 11 | $479.4K |
| Q4 2025 | 11 | $821.1K |
| Q3 2025 | 12 | $818.0K |
| Q2 2025 | 11 | $195.4K |
| Q1 2025 | 11 | $94.9K |
| Q4 2024 | 14 | $19.2K |
| Q3 2024 | 15 | $52.0K |
| Q2 2024 | 18 | $108.0K |
| Q1 2024 | 15 | $832.5K |
| Q4 2023 | 16 | $810.2K |
| Q3 2023 | 15 | $409.0K |
| Q2 2023 | 15 | $133.5K |
| Q1 2023 | 17 | $1.30M |
| Q4 2022 | 14 | $2.77M |
| Q3 2022 | 14 | $7.36M |
| Q2 2022 | 13 | $7.67M |
| Q1 2022 | 14 | $11.2M |
| Q4 2021 | 22 | $4.18M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Starling Oncology, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| LMR Partners LLP | 1,196,386 | $6.05M | 0.11% | +172,395+16.8% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,250,000 | $625.0K | 0.01% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $529.0K | 0.01% | – | – |
| Davidson Kempner Capital Management LP | 318,710 | $159.0K | 0.00% | 00.0% | Unchanged |
| Union Square Park Capital Management, LLC | 120,000 | $60.0K | 0.07% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 118,666 | $59.0K | 0.00% | +26,700+29.0% | Added |
| Difesa Capital Management, LP | 115,975 | $58.0K | 0.04% | −9,025−7.2% | Reduced |
| Jefferies Group LLC | 95,200 | $47.6K | 0.00% | −60,257−38.8% | Reduced |
| Healthcare of Ontario Pension Plan Trust Fund | 87,500 | $44.0K | 0.00% | 00.0% | Unchanged |
| Alpine Global Management, LLC | 25,024 | $13.0K | 0.00% | −25,024−50.0% | Reduced |
| Tenor Capital Management Co., L.P. | 25,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | – | $4.00K | 0.00% | – | – |
| UBS Group AG | 5,474 | $3.00K | 0.00% | +1,000+22.4% | Added |
| Man Group plc | 0 | $0 | 0.00% | −94,740−100.0% | Sold out |